The total return over the past 12 months is +106.79% vs. +16.94% for the S&P 500. So far it's up +83.74% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +106.79% | +84.62% | (1.77%) | N/A | N/A | N/A |
| Total Return CAGR | +106.79% | +84.62% | (1.77%) | N/A | N/A | N/A |
| Revenue CAGR | +50.13% | +17.56% | +18.22% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Adaptive Biotechnologies Corporation (ADPT)
| Year | Start price | End price | ADPT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $16.24 | $29.84 | +83.74% | +14.51% | +69.23% |
| 2025 | $6.00 | $16.24 | +170.67% | +17.72% | +152.95% |
| 2024 | $4.90 | $6.00 | +22.45% | +24.89% | (2.44%) |
| 2023 | $7.64 | $4.90 | (35.86%) | +26.19% | (62.05%) |
| 2022 | $28.06 | $7.64 | (72.77%) | (18.17%) | (54.60%) |
| 2021 | $59.13 | $28.06 | (52.55%) | +28.74% | (81.29%) |
| 2020 | $29.92 | $59.13 | +97.63% | +18.37% | +79.26% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
